Search results
11 lut 2022 · Treatments for aplastic anemia, which will depend on the severity of your condition and your age, might include observation, blood transfusions, medications, or bone marrow transplantation. Severe aplastic anemia, in which your blood cell counts are extremely low, is life-threatening and requires immediate hospitalization.
- Doctors & Departments
Allogeneic stem cell transplant, Acute lymphocytic leukemia,...
- Bone Marrow
Bone marrow is a red, spongy material inside your bones that...
- Doctors & Departments
11 lis 2017 · Approach to diagnosis and treatment of acquired aplastic anemia. Initial screening evaluation of a patient with aplastic anemia is required to document pancytopenia with a hypocellular marrow, followed by testing to exclude alternative diagnoses.
16 lis 2017 · Acquired aplastic anemia (AA) is a rare, life-threatening bone marrow failure (BMF) disorder that affects patients of all ages and is caused by lymphocyte destruction of early hematopoietic cells. Diagnosis of AA requires a comprehensive approach with prompt evaluation for inherited and secondary ca …
22 cze 2021 · There are increasing clinical options for patients with immunosuppressive therapy and transplant once the diagnosis is made. In a case-based format, this review emphasizes the newer data on molecular (somatic and germline) findings in AA and how they are (or are not) helpful during diagnosis.
17 lip 2023 · Explain the treatment and management options available for aplastic anemia. Summarize interprofessional team strategies for enhancing care coordination and communication to advance treatment of aplastic anemia and improve outcomes.
4 gru 2023 · This topic reviews the treatment and prognosis of AA in adults. For adults, the evaluation of pancytopenia; pathogenesis, clinical manifestations, and diagnosis of AA; and hematopoietic cell transplantation for AA are discussed separately. (See "Approach to the adult with pancytopenia".)
16 lis 2017 · Approach to diagnosis and treatment of acquired aplastic anemia. Initial screening evaluation of a patient with aplastic anemia is required to document pancytopenia with a hypocellular marrow, followed by testing to exclude alternative diagnoses.
